Subscribe free

Newsletter

General Surgery

Best Papers in General Surgery

The five that matter, every day.

FreeNo spamOne-click unsubscribe
Obes Surg4 Dec 2023

Evolution of Primary Care Practitioners’ Views on Bariatric Surgery Over a Decade

Over 10 years, a survey involving 452 primary care practitioners in Scotland revealed increased awareness of local bariatric referral criteria, with more making referrals. Despite recognizing the impact of bariatric surgery on weight and related diseases, knowledge gaps persisted regarding national guidelines. Comfort levels in…

Gastrointest Endosc3 Dec 2023

Innovative Closure Strategy for Rectal Defects Post-Endoscopic Submucosal Dissection

Researchers introduced an endoscopic hand-suturing with clips strategy (EHS-clips) for closing rectal defects after endoscopic submucosal dissection (ESD) or ESD with myectomy. All 49 defects achieved complete closure, with 71.4% through EHS alone and 28.6% with additional clips. Zero cases experienced delayed bleeding. Sustained closure…

J Am Coll Surg3 Dec 2023

Augmented Reality Improves Outcomes in Laparoscopic Segmentectomy for Hepatocellular Carcinoma

In a retrospective analysis of 98 hepatocellular carcinoma patients undergoing laparoscopic segmentectomy, augmented reality navigation (ARN) combined with fluorescence imaging (FI) significantly reduced intraoperative blood loss and remnant liver ischemia compared to non-ARN-FI cases. The ARN-FI group exhibited higher 1-year and 3-year disease-free survival rates,…

Ann Surg Oncol3 Dec 2023

Multidisciplinary Clinics Improve Pancreatic Cancer Treatment and Equity

Examining 4141 pancreatic cancer patients, this study in a high-volume hospital system found that Multidisciplinary Clinics (MDCs) significantly boost comprehensive treatment rates, such as neoadjuvant chemotherapy, surgery, palliative care, and clinical trial participation. MDC management effectively eliminates socioeconomic disparities in treatment access, particularly benefiting disadvantaged…

Ann Surg Oncol3 Dec 2023

Biochemical Response Predicts Survival in FOLFIRINOX-Treated Pancreatic Cancer

Evaluating 150 non-metastatic pancreatic ductal adenocarcinoma patients undergoing neoadjuvant FOLFIRINOX chemotherapy, researchers compared biochemical (CA 19-9 normalization) and radiologic responses. Three groups were identified: biochemical responders (BR+), radiology-only responders (BR-/RR+), and non-responders (BR-/RR-). BR+ showed the highest 3-year overall survival (71.0%), significantly better than BR-/RR+…

Ann Surg Oncol3 Dec 2023

Optimal Lymph Node Removal Improves Survival in Gastric Signet-Ring Cell Cancer

Analyzing 1020 patients with gastric signet-ring cell cancer (GSRCC), researchers investigated the relationship between the number of examined lymph nodes (ELNs) and prognosis. X-tile analysis determined the optimal ELN cutoff as 22. Patients with more than 22 ELNs demonstrated higher 5-year overall survival (66.9% vs.…